NCT05826067 Study of E. Coli Isolates From Recurrent Urinary Tract Infections
| NCT ID | NCT05826067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Urinary Tract Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2023-04-20 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2023-04-20 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective study aiming at collecting clinical Escherichia coli isolates from patients with recurrent urinary tract infection; samples to be collected during routine procedures.
Eligibility Criteria
Inclusion Criteria: * patients hospitalized for urinary tract infection, with or without neurological disorders (spina bifida, MS, paraplegic patients) or ambulatory patients diagnosed with a urinary tract infection when the identified causative agent is E. coli * patients who have or are planned to undergo the insertion of a suprapubic catheter * patients who have or are planned to undergo the insertion a nephrostomy catheter Exclusion Criteria: patients * refusing the planned treatment * with therapy compliance * pregnant women * who do not consent to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05826067 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary Tract Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05826067 currently recruiting?
Yes, NCT05826067 is actively recruiting participants. Contact the research team at francoise.vanbambeke@uclouvain.be for enrollment information.
Where is the NCT05826067 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT05826067 clinical trial?
NCT05826067 is sponsored by Université Catholique de Louvain. The trial plans to enroll 45 participants.